Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
Gelb, Arthur F., M.D. · NCT03263130
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 30+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 60
- US sites recruiting
- 2
- Study start
- January 1, 2017
- Record last updated
- October 27, 2023
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (>15 pack years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatment may include short and long acting inhaled beta2agonists, short and long acting inhaled muscarinic receptor antagonists, inhaled and or oral corticosteroid, oral antibiotic, supplemental oxygen, and PDE type 4 inhibitor. In some cases, the patient may have had a history of asthma preceding the development of COPD (Asthma COPD Overlap).
Being studied: As above: diagnosis: COPD, Emphysema, Asthma-COPD Overlap
Conditions: COPD, Emphysema, Asthma COPD Overlap; Emphysema
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- asthma- copd overlap
- emphysema in smokers with smoking history > 15 pack years
- COPD/ bronchitis and bronchiectasis in smokers with smoking history
- >15 pack years
Exclusion Criteria:other pulmonary or systemic diagnosis
- non smokers
- any other pulmonary diagnosis
- pulmonary fibrosis
Recruiting US locations
Arthur F Gelb MD
Lakewood, CA 90712
Site contact: Arthur F Gelb, MD · 562-633-2204 · afgelb@msn.com
Arthur F Gelb MD
Lakewood, CA 90712
Site contact: Arthur F Gelb, MD · 562-633-2204 · afgelb@msn.com
Study contacts (from the official record)
- Arthur F Gelb, MD · 562-633-2204 · afgelb@msn.com
- Christine Fraser · 562-633-2204 · familyfrase@msn.com
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55